Medication tolerance and augmentation in restless legs syndrome: The need for drug class rotation

Journal of General Internal Medicine

Volumn 21, Issue 12, 2006, Pages

  Kurlan, Roger ^a   Richard, Irene Hegeman ^a,b   Deeley, Cheryl ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Mt Hope Professional Building ^*  (United States)

Author keywords

Analgesics; Benzodiapezines; Dopamine agonists; Levodopa; Restless legs syndrome

Indexed keywords

CARBIDOPA; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GABAPENTIN; HYDROCODONE; LEVODOPA; NARCOTIC AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; ZOLPIDEM;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG TOLERANCE; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HUMAN; LAMINECTOMY; NAUSEA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RESTLESS LEGS SYNDROME; SEDATION; SIDE EFFECT; SPINE FUSION; TITRIMETRY; TREATMENT RESPONSE; VERTEBRAL CANAL STENOSIS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY DISEASE; DIABETES COMPLICATIONS; EDUCATIONAL STATUS; FEMALE; HEALTH EDUCATION; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MANAGED CARE PROGRAMS; MEDICARE; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RESTLESS LEGS SYNDROME;

EID: 33750496240     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00593.x     Document Type: Article

References (21)

1. Clough C. Restless legs syndrome. Br Med J. 1987;294:262-3.
2. Rama AN, Kushida CA. Restless legs syndrome and periodic limb movement disorder. Med Clinics N Am. 2004;88:653-67.
3. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:560-83.
4. Earley CJ. Restless legs syndrome. N Engl J Med. 2003;348:2103-9.
5. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79:916-22.
6. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:465-75.
7. Happe S, Klösch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentine. Neurology. 2001;57:1717-9.
8. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Marsramon X, Hernandez G. Treatment of restless legs syndrome with gabapentine: a double-blind, cross-over study. Neurology. 2002;59:1573-9.
9. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200-3.
10. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19:205-13.
11. Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs syndrome and rebound phenomenon. Neurology. 1993;43:445.
12. Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52:285-90.
13. Stiasny K, Wetter TC, Trenkwalder C, Oertel WH. Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism Relat Disord. 2001;7:21-5.
14. Comella CL. Restless legs syndrome: treatment with dopaminergic drugs. Neurology. 2002;58:S87-S92.
15. Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med. 2004;5:9-14.
16. Garcia-Borreguero D, Lee D, Ball E. Ropinirole is well tolerated and effective for the long-term treatment of RLS. Neurology. 2005;64:A42.
17. Vetrugno R, Contin M, Baruzzi A, et al. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless leg syndrome. Mov Disord. 2006;21:254-8.
18. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75:92-7.
19. Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414-23.
20. Bogan RK, Fry JM, Schmidt MH, et al. Ropinirole in the treatment of patients with restless legs syndrome: a U.S.-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81:17-27.
21. Bliwise DL, Freeman A, Ingram CD, et al. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome. Sleep Med. 2005;6:141-7.